Intermolecular Aliphatic C-H Functionalization Using Heteroatom-Centered Radicals
Intermolecular Aliphatic C-H Functionalization Using Heteroatom-Centered Radicals
批准号:
9330868
负责人:
Erik John Alexanian
金额:
$27.28万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2020-07-31
关键词:
AcidsAddressAlkylationBiologicalBiological SciencesChemicalsComplexComputer SimulationCoupledDataDevelopmentElectron TransportFutureGenerationsGoalsHealthHydrogen BondingIn SituMediatingMetalsMethodsModificationN hydroxylationNatural ProductsNatural regenerationNitrogenOutcomeOxidation-ReductionPreparationProcessProtonsPublic HealthReactionReagentResearchRouteSiteTechnologyTherapeutic AgentsVariantVisible RadiationWorkanalogbasebioactive natural productsc newcarbenecatalystchemical functionchemical synthesisdecalindesigndrug synthesishalogenationimprovedinnovationnext generationnovelnovel therapeuticssmall moleculesmall molecule therapeuticstool
中文摘要
项目摘要:化学合成在健康相关研究中的应用与有效获取密切相关
英文摘要
Project Summary: The utility of chemical synthesis in health-related research is closely tied to efficient access
to therapeutic agents. The synthesis of these compounds using standard approaches often involves lengthy,
inefficient synthetic routes, hindering the discovery and development of new drugs. Synthetic transformations
that selectively functionalize aliphatic C–H bonds hold significant promise in streamlining drug synthesis and
providing access to novel analogs of biologically relevant compounds that would otherwise be challenging to
obtain. Despite the potential for site-selective C–H functionalization, few intermolecular processes of
preparative value exist. This gap in reaction development fundamentally limits the use of C–H functionalization
in the synthesis of medicinally valuable, functionalized small molecules. The long-term goal of this research is
the development of practical, intermolecular aliphatic C–H functionalizations that introduce diverse chemical
functionality and proceed with high levels of selectivity. The overall objective of this application is to develop a
new C–H functionalization that unlocks a diverse set of currently inaccessible, valuable C–H transformations,
and to further enhance the site selectivities and chemoselectivities of our approach using heteroatom-centered
radicals. We will also develop catalytic variants, offering new opportunities in both reagent design and reaction
development. Our research is based on the central hypothesis that radical-mediated intermolecular C–H
functionalizations offer superior site selectivities and chemoselectivities and will enable the development of
new transformations that are inaccessible via metal-catalyzed approaches. The rationale of the proposed
research is that these practical and selective reactions will facilitate access to diverse synthetically and
medicinally valuable small molecules. This work involves three specific aims: (1) to develop an aliphatic C–H
xanthylation (dithiocarbonation) as a platform technology for C–H functionalization; (2) to increase the site
selectivity and chemoselectivity of intermolecular C–H functionalizations using heteroatom-centered radicals;
and (3) to develop catalytic variants of the radical-mediated C–H functionalizations. Under the first aim, we will
develop a practical, efficient method for aliphatic C–H xanthylation. In the second aim, we will enhance both
the site selectivity and chemoselectivity of our platform using heteroatom-centered radicals. Under the third
aim, we will develop catalytic, intermolecular aliphatic C–H functionalizations. Our proposed research is
innovative because it will establish the unique capabilities of intermolecular aliphatic C–H functionalization
using tuned radical species in unlocking new, practical transformations of aliphatic C–H bonds with superior
levels of site selectivity and chemoselectivity. These contributions are significant because they will offer a
range of practical and predictable aliphatic C–H transformations for late-stage functionalizations, catalyzing the
discovery and development of next generation biologically active natural products and medicinal agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Innovative Transformations of Fundamental Synthetic Building Blocks
-
批准号:10397531
-
项目类别:
-
资助金额:$49.6万
-
财政年份:2019
-
负责人:Erik John Alexanian
-
依托单位:
Innovative Transformations of Fundamental Synthetic Building Blocks
-
批准号:10598008
-
项目类别:
-
资助金额:$49.6万
-
财政年份:2019
-
负责人:Erik John Alexanian
-
依托单位:
Innovative Transformations of Fundamental Synthetic Building Blocks
-
批准号:9922930
-
项目类别:
-
资助金额:$49.6万
-
财政年份:2019
-
负责人:Erik John Alexanian
-
依托单位:
Catalytic Approaches to C-C Bond Formation Using Alkyl Halides
-
批准号:9033923
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2014
-
负责人:Erik John Alexanian
-
依托单位:
海外基金